4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000021
Options or other derivatives
- Chief Executive Officer acquired 99,800 shares (grant or award)
From the SEC's structured data for this filing
Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000021
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…